Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411500 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males
A Phase 1 study, sponsored by Trevena.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT02411500 is a Phase 1 study that has completed, run by Trevena. The registered enrollment target is 18 participants.
The verdict
NCT02411500, a Phase 1 study, has completed, sponsored by Trevena.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the pharmacokinetics of various TRV734 formulations in healthy male subjects.
Interventions
- DRUG TRV734
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02411500
The ClinicalTrials.gov registry entry for NCT02411500 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trevena, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TRV734 is the first listed.
NCT02411500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02411500 about?
NCT02411500 is a clinical study titled "A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males". The primary objective of this study is to evaluate the pharmacokinetics of various TRV734 formulations in healthy male subjects.
What is the current status of trial NCT02411500?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2015-02. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02411500?
The interventions under investigation include: TRV734 (DRUG).
Who is sponsoring clinical trial NCT02411500?
This trial is sponsored by Trevena, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.